Cargando…
Molecular Profiles of Brain Metastases: A Focus on Heterogeneity
SIMPLE SUMMARY: Precision cancer medicine depends on the characterization of tumor samples, usually by a single-tumor biopsy, to administer an optimal therapeutic. However, primary tumors and their metastases are often heterogeneous. A metastatic lesion may harbor a completely different genetic make...
Autores principales: | Ali, Shan, Górska, Zuzanna, Duchnowska, Renata, Jassem, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198739/ https://www.ncbi.nlm.nih.gov/pubmed/34071176 http://dx.doi.org/10.3390/cancers13112645 |
Ejemplares similares
-
Patient Eligibility and Results for Brain Metastasis in Phase 3 Trials of Advanced Breast Cancer: A Scoping Review
por: Duchnowska, Renata, et al.
Publicado: (2021) -
The Usefulness of Prognostic Tools in Breast Cancer Patients with Brain Metastases
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022) -
Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy
por: Niwinska, Anna, et al.
Publicado: (2022) -
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
por: Nicoś, Marcin, et al.
Publicado: (2022) -
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
por: Duchnowska, Renata, et al.
Publicado: (2012)